Balance Sheet

Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Growth Metrics

Medicure (MCUJF) Change in Account Payables (2016)

Medicure has reported Change in Account Payables over the past 2 years, most recently at $155150.0 for Q3 2016.

For Q3 2016, Change in Account Payables changed N/A year-over-year to $155150.0; the TTM value through Sep 2016 reached $155150.0, changed N/A, while the annual FY2015 figure was $1.3 million, 306.35% up from the prior year.
Change in Account Payables for Q3 2016 was $155150.0 at Medicure, down from $1.3 million in the prior quarter.
Over five years, Change in Account Payables peaked at $1.3 million in Q4 2015 and troughed at $155150.0 in Q3 2016.